22 March 2021 Communicable Disease COVID-19 Live blog Phase 1b of vaccine rollout launches amid flood havoc
19 March 2021 Communicable Disease COVID-19 Live blog Only 40% of seropositive people have neutralising antibodies
17 March 2021 Communicable Disease COVID-19 Live blog Study raises questions about AstraZeneca vaccine efficacy
16 March 2021 Communicable Disease COVID-19 Live blog SARS-CoV-2 interrupts function of heart muscle cells
15 March 2021 Communicable Disease COVID-19 Live blog Post-vaccine lymphadenopathy may affect breast screening
12 March 2021 Communicable Disease COVID-19 Live blog Thrombosis concerns with European batch of AstraZeneca vaccine
11 March 2021 Communicable Disease COVID-19 Live blog Long COVID associated with high symptom count early in infection
10 March 2021 Communicable Disease COVID-19 Live blog Delay surgery at least seven weeks after infection
9 March 2021 Communicable Disease COVID-19 Live blog Vaccine anaphylaxis rate just 0.025%, study finds
8 March 2021 Communicable Disease COVID-19 Live blog France eyeing Australia’s vaccine supply amid EU shortage
5 March 2021 Communicable Disease COVID-19 Live blog Drop in ventilated patients in Israel with vaccine roll-out
4 March 2021 Communicable Disease COVID-19 Live blog Faintness, headache and nausea most common vaccine side effects
3 March 2021 Communicable Disease COVID-19 Live blog Antibodies persist eight months after mild infection
